Excerpt of tHEORetically Speaking blog post sponsored by Veradigm
Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossi 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes.
Real-world studies have evaluated diagnostic gaps, risk factors, clinical predictors, and long-term outcomes for NAFLD.The real-world evidence (RWE) obtained from these studies demonstrates an ongoing need for identifying individuals with NAFLD, stratifying risk, and referring patients to specialists.
This blog presents a retrospective cohort study using de-identified real-world data sourced from a cloud-based, U.S. electronic health record (EHR) dataset offered by Veradigm® as part of its Health Insights database. The dataset includes ambulatory patients seen by primary care and specialty healthcare providers (practice size ranging from one to four clinicians).
The objectives of the current analysis were to:
- Establish the prevalence of NAFLD over a five-year period;
- Characterize the all-inclusive NAFLD cohort and NAFL and NASH subgroups; and,
- Identify which provider types are seeing NAFLD patients.
To read the full blog post on tHEORetically Speaking, the official blog of HealthEconomics.Com© LLC, click here.